However, adjunctive administrations of ZOL/IL2 in Group-2 macaques readily increased numbers of some anti-TB γδ and αβ T effector populations in airway BAL fluid at week 3 until week 19 or 21 after MDR-TB infection, although entire T effector cells in airway were less consistently detected overtime. The gene discussed is IL2; the disease is tuberculosis.